Skip to content

Medical-device intelligence

JTN: Susceptibility Test Discs, Antimicrobial

FDA product code JTN: Susceptibility Test Discs, Antimicrobial. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JTN
FDA device name
Susceptibility Test Discs, Antimicrobial
Device class
2
Regulation number
866.1620
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

331 clearance records and 47 recall records in the covered releases, across 30 source company names and 1 product codes. Dated history runs from Nov 16, 1976 to Aug 20, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202510
December 202510
January 202600
February 202600
March 202600
April 202600
May 202610
June 202601
July 202620
August 202610
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JTN · Susceptibility Test Discs, Antimicrobial33147

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

378 matching records
Device / recordCompany in FDA recordSourceSource date
HardyDisk AST Tebipenem 10µg (TBP10)K262113 · JTNHardy Diagnostics510(k)Aug 20, 2026FDA decision date
HardyDisk AST Cefiderocol 30g (FDC30) REF Z9435 HardyDisk AST Cefiderocol 30g (FDC30) for in vitro agar diffusion susceptibility testing is ind…Z-2887-2026 · JTNHardy DiagnosticsRecallAug 5, 2026FDA classification date
Thermo Scientific Oxoid Cefepime/Zidebactam Disc (30/30 µg) FPZ60K261781 · JTNThermo Fisher Scientific (Oxoid Ltd.)510(k)Jul 24, 2026FDA decision date
Gepotidacin GEP 10 µgK261853 · JTNLiofilchem, Inc.510(k)Jul 23, 2026FDA decision date
HardyDisk AST Gepotidacin 10µg (GEP10)K260842 · JTNHardy Diagnostics510(k)May 11, 2026FDA decision date
Thermo Scientific Oxoid Gepotidacin Disc (10 µg) GEP10K251337 · JTNThermo Fisher Scientific (Oxoid Ltd.)510(k)Dec 5, 2025FDA decision date
HardyDisk AST Cefiderocol 30µg (FDC30)K253105 · JTNHardy Diagnostics510(k)Nov 20, 2025FDA decision date
Sulopenem SPM 2 µgK251879 · JTNLiofilchem510(k)Aug 12, 2025FDA decision date
HardyDisk AST Gepotidacin 10µg (GEP10)K250956 · JTNHardy Diagnostics510(k)Jun 26, 2025FDA decision date
Ceftobiprole BPR 5 µg DiscK250885 · JTNLiofilchem, Inc.510(k)Jun 23, 2025FDA decision date
Thermo Scientific Oxoid Aztreonam/Avibactam Disc (30/20 µg) AZA50K250789 · JTNThermo Fisher Scientific (Oxoid Ltd.)510(k)Jun 12, 2025FDA decision date
HardyDisk Aztreonam/Avibactam 30/20µg (AZA50)K250454 · JTNHardy Diagnostics510(k)May 15, 2025FDA decision date
Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797Z-1075-2025 · JTNOxoid LimitedRecallFeb 4, 2025FDA classification date
BD BBL Sensi Disc Ampicillin 2 g (AM-2) - In-Vitro BD BBL Sensi Disc Ampicillin 2 g (AM-2) are used for semi-quantitative in vitro susceptibility…Z-0621-2025 · JTNBecton Dickinson & Co.RecallDec 5, 2024FDA classification date
HardyDisk AST Cefiderocol 30µg (FDC30)K241060 · JTNHardy Diagnostics510(k)Jul 18, 2024FDA decision date
Thermo Scientific Oxoid Rezafungin Disc (5 µg) RZF5K231806 · JTNOxoid Limited (Part of Thermo Fisher Scientific)510(k)Mar 22, 2024FDA decision date
Sensi Disc Amoxicillin with Clavulanic Acid 20/10 g, Catalog No. 231628 and 231629. These discs are used for semi-quantitative in vitro suscept…Z-1011-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ampicillin - 10 g, Catalog No. 230705 and 231264; 2 g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility t…Z-1012-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing.Z-1013-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Augmentin - 3g, Catalog Number 291270used for semi-quantitative in vitro susceptibility testing.Z-1014-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Azithromycin -15 g, Catalog Number 231682used for semi-quantitative in vitro susceptibility testing.Z-1015-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Aztreonam - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640and 231641.Z-1016-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefaclor - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653Z-1017-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefepime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696Z-1018-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date
BD BBL Sensi Disc Cefixime - 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664Z-1019-2024 · JTNBecton Dickinson & Co.RecallFeb 8, 2024FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗